Mazen Juratli- Medicine- Outstanding Scientist Award

Mazen Juratli- Medicine- Outstanding Scientist Award

Prof. Mazen Juratli distinguished academic and researcher in the field Medicine. He is a dedicated and accomplished Assistant Professor and Senior Consultant Surgeon with a strong background in General, Visceral, and Transplant Surgery, specializing in upper GI tumors, reflux surgery, and peritoneal carcinomatosis. His experience encompasses both the clinical and research facets of surgical oncology, demonstrating a steadfast dedication to advancing medical science and enhancing patient care. He is actively pursuing opportunities to make substantial contributions to the field of surgery and academic medicine, particularly in the realm of Upper GI and peritoneal carcinomatosis surgery, along with related areas.

🌐 Professional Profile

Educations📚📚📚

He earned his Ph.D. in Interdisciplinary Biomedical Science (IBS) from the Arkansas Nanomedicine Center at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR, USA, completing his studies between January 2012 and May 2014. Prior to that, he attended medical school at Philipps University in Marburg, Germany, from October 2003 to November 2009.

 Experience:

He is currently an Assistant Professor and Senior Consultant Surgeon at the University Hospital of Muenster in Muenster, Germany, within the Department of Generalhttps://networkscience-conferences.researchw.com/?p=33910&preview=true, Visceral, and Transplant Surgery. He specializes as an Upper Gastrointestinal (GI) Surgeon, adept in robotic, minimally invasive, and open surgeries. Additionally, he heads the Stomach Cancer and Peritoneal Carcinomatosis Surgical Center, serves as Deputy Head of the Esophagus Cancer Center, and leads the Surgical Biobank. He is also the Principal Investigator (PI) for the Liquid Biopsy Research Group. His licensure and certifications include being a Senior Explant Surgeon for Donor Surgery: Liver and Kidney (since October 2023) and a Certified Center Surgeon for the Upper GI Tract (since January 2023). He is a member of the Board of Directors of the Interdisciplinary Working Group for Clinical Hemotherapy (IAKH e.V.) and holds an additional qualification in Specialized Visceral Surgery (Zusatzbezeichnung Spezielle Viszeralchirurgie) from the Ärztekammer Westfalen-Lippe, Germany, since September 2022. He became a Fellow of the European Board of Surgery (F.E.B.S.) in Surgical Oncology in September 2022 and has been an Assistant Professor (Privatdozent Dr. med. habil.) since January 2021. He has served as a Senior Consultant Surgeon (Oberarzt) in the Department of General, Visceral, and Transplant Surgery at the University Hospital of Muenster since September 2020. He obtained his German Board Certification in Visceral Surgery – Consultant Surgeon (Facharzt) from the Ärztekammer Hessen, Germany, in June 2019. He earned his Ph.D. from the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR, USA, in December 2014 and his Doctor of Medicine (Dr. med.) from Philipps University in Marburg, Germany, in December 2009, where he also obtained his German Federal License (Approbation) in November 2009.

Awards, Grants and Honors

He has received numerous awards, grants, and honors throughout his career. In 2024, he secured industrial grant funding from Johnson & Johnson for a project on surgical smoke exposure investigation in surgical safety, amounting to €169,681, and also received the German Society for General and Visceral Surgery (DGAV) Travel Award, valued at €5000. He earned abstract prizes for his pilot studies on diagnostic and prognostic tumor markers in adenocarcinomas of the gastroesophageal junction and extracellular vesicles as potential biomarkers for hepatocellular carcinoma, presented at Visceral Medicine 2023 in Hamburg and NRW-Visceral Medicine 2023 in Essen, each prize valued at €500. In 2022, he won another abstract prize for his work on the long-term effects of liver resection on circulating stem cells in hepatocellular carcinoma, presented at Visceral Medicine in Hamburg. He was recognized as a Medical Scientist by the Else Kröner-Forschungskolleg (EKFK) in 2018 and received a grant of €15,000 from the B. Braun-Stiftung the same year. In 2017, he was awarded €66,000 for young talent promotion by Frankfurt Research Promotion at Goethe University, Frankfurt am Main, Germany. His achievements also include the Frankfurt Research Prize of the Rudolf Geißendörfer Foundation in 2015, valued at €5,000, and a poster prize at the 19 Chirurgische Forschungstage in Würzburg, Germany, in 2015, valued at €500. He received the second prize for the Cancers Best Paper Award in 2015 and the German Academic International Network (GAIN) Travel Award to attend the 18th European Career Fair (ECF) in Boston, MA, USA, in 2014, valued at €2,000. He was honored with the People’s Choice award for Science as Art at the Nanotechnology for Health Care Conference in Petit Jean, AR, USA, in 2014. Additionally, he was granted $78,000 by the Arkansas Breast Cancer Research Program (ABCRP) in 2013 and received €50,000 from the DFG – German Research Foundation in 2012.

 

📝🔬Publications📝🔬

  • Jens Hoelzen, Lukas Fortmann, Dhruvajyoti Roy, Carsten Szardenings, Martina Holstein, Ann-Kathrin Eichelmann,Emile Rijcken,Brooke E. Frankauer, Peter Barth, Eva Wardelmann, Andreas Pascher, and Mazen A. Juratli. Robotic-Assisted Esophagectomy with Total Mesoesophageal Excision EnhancesR0-Resection in Patients with Esophageal Cancer – a single-center experience. Surgery 05/2024. In Press
  • Lamberty SA, Hoelzen JP, Katou S, Becker F, Juratli MA, Andreou A, Morgül MH, Pascher A, Strücker B. Validation of the IWATE Criteria in Robotic-Assisted Liver Resections. J Clin Med. 2024 May 3;13(9):2697. doi: 10.3390/jcm13092697. PMID: 38731226; PMCID: PMC11084793.
  • Juratli, M.A., Pollmann, N.S., Oppermann, E. et al. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma. Sci Rep 14, 5322 (2024). https://doi.org/10.1038/s41598-024-55888-8.
  • Diedrich AM, Daneshgar A, Tang P, Klein O, Mohr A, Onwuegbuchulam OA, von Rueden S, Menck K, Bleckmann A, Juratli MA, Becker F, Sauer IM, Hillebrandt KH, Pascher A, Struecker B. Proteomic analysis of decellularized mice liver and kidney extracellular matrices. J Biol Eng. 2024 Feb 22;18(1):17. doi: 10.1186/s13036-024-00413-8. PMID: 38389090; PMCID: PMC10885605
  • de Jongh C, Cianchi F, Kinoshita T, Kingma F, Piccoli M, Dubecz A, Kouwenhoven E, van Det M, Mala T, Coratti A, Ubiali P, Turner P, Kish P, Borghi F, Immanuel A, Nilsson M, Rouvelas I, Hӧlzen JP, Rouanet P, Saint-Marc O, Dussart D, Patriti A, Bazzocchi F, van Etten B, Haveman JW, DePrizio M, Sabino F, Viola M, Berlth F, Grimminger PP, Roviello F, van Hillegersberg R, Ruurda J; UGIRA Collaborative Group. Surgical Techniques and Related Perioperative Outcomes After Robot-assisted Minimally Invasive Gastrectomy (RAMIG): Results From the Prospective Multicenter International Ugira Gastric Registry. Ann Surg. 2023 Nov 3. doi: 10.1097/SLA.0000000000006147. Epub ahead of print. PMID: 37922237.
  • Hoelzen JP, Frankauer BE, Szardenings C, Roy D, Pollmann L, Fortmann L, Merten J, Rijcken E, Juratli MA, Pascher A. Reducing the Risks of Esophagectomies: A Retrospective Comparison of Hybrid versus Full-Robotic-Assisted Minimally Invasive Esophagectomy (RAMIE) Approaches. J Clin Med. 2023 Sep 7;12(18):5823. doi: 10.3390/jcm12185823. PMID: 37762765; PMCID: PMC10531670.Two senior authors
  • Peters AK, Juratli MA, Roy D, Merten J, Fortmann L, Pascher A, Hoelzen JP. Factors Influencing Postoperative Complications Following Minimally Invasive Ivor Lewis Esophagectomy: A Retrospective Cohort Study. J Clin Med. 2023 Aug 31;12(17):5688. doi: 10.3390/jcm12175688. PMID: 37685756; PMCID: PMC10488704.Contributed equally to the study
  • Mohr A, Besser M, Broichhausen S, Winter M, Bungert AD, Strücker B, Juratli MA,Pascher A, Becker F. The Influence of Apremilast-Induced Macrophage Polarization on Intestinal Wound Healing. J Clin Med. 2023 May 9;12(10):3359. doi: 10.3390/jcm12103359. PMID: 37240465; PMCID: PMC10219563

Sahar Essa -Virology – Excellence in Research

Dr. Sahar Essa  distinguished academic and researcher in the field  Biological Networks (Virology, Immunology, Cytokines).  In her academic career, she has held various positions at Kuwait University, beginning as a Teaching Assistant in the Faculty of Medicine from 1992 until 2012, when she progressed to the role of Assistant Professor, a position she continues to hold to date.

Her professional journey also includes experiences beyond Kuwait. She served as a Research Assistant at the Department of Pathology in McGill University, Canada, from 1990 to 1991, contributing to the research efforts in her field. Prior to her international stint, she worked as an Academic Assistant in the Department of Microbiology at the Faculty of Medicine in Kuwait from 1986 to 1989, laying the groundwork for her future academic endeavors. Throughout her career, she has demonstrated a commitment to both academic excellence and research advancement in the field of biological sciences.

🌐 Professional Profiles

Educations📚📚📚

She holds a Ph.D. in Medical Virology from Warwick University, United Kingdom, which she obtained in 2001. Prior to that, she completed her Master of Science in Medical Microbiology at the Faculty of Medicine, Kuwait University, in 1989. Her academic journey commenced with a Bachelor of Science in Medical Technology from Kuwait University in 1985. Throughout her educational endeavors, she has specialized in various fields within Biological Sciences, establishing a strong foundation in medical research and microbiology.

RESEARCH EXPERIENCE

As a Principal Investigator, she has spearheaded several research projects, each aimed at advancing knowledge in the field of virology and immunology. One such project focused on sequencing Human Polyomaviruses WU from patients with Lower Respiratory Tract Infection in Kuwait. This endeavor, funded by Kuwait University, saw fruitful results with one full-length paper published in Medical Principles and Practice in 2017, showcasing the significance of her findings.

Another notable project delved into the immunophenotyping of peripheral blood cells in response to infection with major HCV genotypes before, during, and after treatment. With funding support from Kuwait University, this research effort yielded a comprehensive paper published in Medical Principles and Practice in 2021, shedding light on the modulation of immune cell subsets by Hepatitis C Virus (HCV) and antiviral therapy.

Additionally, she led investigations into the influence of neutrophils on the production of cytokines associated with different Th cell subsets in chronic HCV-infected patients. This study, funded by Kuwait University, resulted in a significant publication in Pathogens in 2021, highlighting the modulation of cytokine production in peripheral blood mononuclear cells and neutrophils by HCV infection.

Furthermore, she contributed to understanding the influence of SARS-COV-2 on cytokine production by peripheral blood mononuclear cells and neutrophils in COVID-19 patients. Supported by KFAS, this research, completed in 2021, added valuable insights into the cytokine responses in individuals affected by the COVID-19 virus. Throughout her career, she has demonstrated a strong commitment to research excellence, making significant contributions to the scientific community’s understanding of viral infections and immune responses.

Number of citations

  • Number of citations:
    • Total 396
    • Previous 5 years (2017-2022) 138
  • h-index
    • Total 13
    • Previous 5 years (2017-2022) 8
  • i10- index
    • Total 14
    • Previous 5 years (2017-2022) 6

CONFERENCES:

As a member of various organizing committees, she has been instrumental in orchestrating numerous virology symposiums aimed at updating professionals on modern trends, recent advances, and updates in clinical virology. From 2002 to 2013, she contributed to organizing symposiums such as “Modern Trends in Clinical Virology,” “Update in Clinical Virology,” and “Recent Advances in Clinical Virology” at the AbdulRazak Lecture Theater, Health Science Center, fostering knowledge exchange and collaboration in the field.

Furthermore, her expertise has been sought after globally, with invitations to speak at prestigious conferences and symposiums. She has addressed audiences on a wide range of topics related to clinical virology, including presentations on cytomegalovirus infections, persistent viral infections, and the influence of various viruses on immune responses. Notably, she has participated in international conferences such as the BIT’s 1st World Congress of Viruses and Infections in South Korea, the 3rd Global Virology Congress & Expo in Spain, and the 10th International Virology Summit in Austria, where she shared her insights and research findings with fellow experts in the field.

Moreover, she has actively contributed to conferences with presentations, showcasing her research on topics such as the role of respiratory syncytial virus in respiratory diseases and the diagnosis and management of viral infections in transplant recipients. Her presence and contributions at these events have underscored her dedication to advancing the understanding and management of viral infections through research, collaboration, and knowledge dissemination.

Continuous Professional Development (Courses and Workshops)

She has demonstrated a commitment to continuous professional development through her participation in various courses and workshops spanning diverse topics in the field of medical science. From acquiring diplomas in workshops on laboratory techniques to enhancing teaching and learning methodologies, she has continuously upgraded her skills and knowledge. Her attendance at workshops focusing on clinical teaching, infectious diseases, laboratory management, and infection control underscores her dedication to staying updated with the latest advancements in her field. Furthermore, her engagement in workshops on radiation protection, fire safety, and updates on infection control highlights her commitment to maintaining a safe and secure working environment. Additionally, her participation in workshops on bioinformatics, genomics, and scientific writing reflects her enthusiasm for exploring emerging areas of research and honing her skills in data analysis and communication. Through her proactive approach to professional development, she ensures her expertise remains current and relevant in the ever-evolving landscape of medical science.

She has been honored with several prestigious awards throughout her career, recognizing her outstanding achievements and contributions to the field of medical science. In 1985, she was awarded a gold medal for achieving the highest total marks in her B.Sc. degree from the Faculty of Allied Health at Kuwait University, reflecting her academic excellence and dedication to her studies. Her research endeavors have also been recognized, with awards such as the Best Clinical Sciences Research at the 11th Annual Health Sciences Center Poster Conference in April 2006, highlighting the quality and significance of her contributions to clinical research. Additionally, she received the Best Poster Award at the 10th International Virology Summit in Vienna, Austria, in July 2018, and another Best Poster Award at the International Conference on Infectious and Rare Diseases in Amsterdam, Netherlands, in August 2019, further affirming the impact and recognition of her research at the international level. These honors underscore her commitment to excellence and innovation in the field of medical virology.

 

Publications

 

 

 

 

Panagiotis Karanis – Biomedical Research – Best Researcher Award

Panagiotis Karanis – Biomedical Research

Dr. Panagiotis karanis  distinguished academic and researcher in the field Biomedical research, infectious diseases, climate changes.  Professor Karanis is a resourceful and dedicated professor with an impressive academic background,
excellent publication record and significant teaching experiences in the fields of Emerging Infectious
Parasitic and Tropical Diseases and Human Anatomy. Possesses excellent interpersonal and liaison skills
with the ability to build and maintain positive working relationships. Possesses mature administrative and
managerial skills and solid experience in science policy and public health. Enjoys worldwide collaborating
in a productive and successful team and thrives in challenging environments. He was 1000 Talent Plan
Expert (2014-2017) in Qinghai, China.

🌐 Professional Profiles

Educations: 📚🎓

Professor Dr. Panagiotis Karanis has held various esteemed positions in the field of anatomy and biomedicine, showcasing an extensive and distinguished career spanning several decades. From 2019 to the present, he serves as a Professor of Anatomy and the Coordinator of the Unit of Anatomy & Morphology at the Medical School, University of Nicosia, Nicosia, Cyprus. His contributions extend globally, as he has been an international advisor, consultant, and visiting professor at numerous universities.

During the period from 2014 to 2018, Professor Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at the State Key Laboratory for Plateau Ecology and Agriculture at Qinghai University in Xining, China. His expertise was recognized internationally, as he was selected as a Foreign Expert in the 1000 Talent Plan, Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese experts in China.

Earlier in his career, from 2009 to the present, Professor Karanis made significant contributions as a Professor of Anatomy at the Medical School, University of Cologne, Germany. Prior to this, he served as an Associate Professor and later as a Full Professor at the National Research Centre for Protozoan Diseases (NRCPD) in Japan from 2006 to 2007.

The trajectory of Professor Karanis’s career is marked by academic achievements. In 1999, he received Venia legendi in Parasitology (PD Dr.) and completed his Habilitation in Clinical-Theoretical Medicine at the Medical Faculty, University of Bonn, Germany. His academic journey began with a PhD in Parasitology, focusing on ‘UV-Disinfection of Protozoan Parasites’ at the University of Bonn in 1992. Earlier, in 1987, he earned a Diploma in Biology from the University of Bochum, Germany.

Professor Karanis’s educational background is diverse, including studies in Biology at the Universities of Bielefeld, Düsseldorf, and Bochum from 1980 to 1986. He also pursued complementary studies of Medicine at the Universities of Bochum and Cologne, completing the pre-clinical medical curriculum. His commitment to academia and research has made him a respected figure in the international scientific community, contributing significantly to the fields of anatomy, biomedicine, and parasitology.

Research Interests: 🧬🔬

Biomedical research, infectious diseases, climate changes,Applications of Network Science and Graph Analytics in Social, Biological, and Technological Networks

Awards and Achievements: 🏆👏

  •  Prof. Karanis is included on the annual list of 100,000 top scientists worldwide and, correspondingly, in
    the top 2 per cent of scientists in their field, according to a team of researchers at Stanford University in
    the USA. The updated 2020 list is based on a range of citation metrics that provides standardized data
    across those fields and subfields, in arriving at the (2019) single year impact result of more than 8,000,000
    scientists worldwide.
  • Gained worldwide administrative and managerial skills and experiences in science policy and public
    health. Successfully established 5 Laboratories / Institutions in Bonn / Germany (Waterborne and Vectorborne
    Parasitic Diseases), Thessaloniki / Greece (Leishmania and Sandflies), Cologne / Germany (Medical and
    Molecular Parasitology), Obihiro / Japan (Unit for Diseases Control and Genetics), Xining / China (Centre
    of Biomedicine and Infectious Diseases; the laboratory was promoted from the Chinese Government toState Key Laboratory of the Qinghai Province in China, 2016). The laboratories in Germany, Japan and
    China achieved an international reputation
  • Developed worldwide effective cooperations between many countries, in particular betweenEuropean
    and Asian countries
  •  Consultant at Qatar National Research Foundation and Qatar University, Doha, Qatar
  • Academic program review for the Master of Science in Biomedical Science, College of Health
    Sciences at Qatar University, Doha, Qatar, September 2018
  • Consultant” at Walailak University, Nakhon Si Thammarat, Thailand
  • Nominated as “Advisory Board Member” of the “Centre of Excellence for Medical Research and
    Innovative Products (CEMRIP)” in Thailand.
  • Nominated “National Distinguished Expert” and “State Specially Recruited Expert” of China
  • Selected in 1000 Talent Plan, the Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese
    experts, China, 2014, leading into ongoing innovative and promising collaborations with China
  • Invitation for Short Term – Fellowship – Program for Malaria Research in Japan by JSPS (Japanese
    Society of Promotion of Science), 12th January – 11th March 2014

Career Summary 

Dr. Panagiotis Karanis is a distinguished parasitologist with a wealth of expertise and a prolific career spanning several prestigious institutions across the globe. Serving as a Guest Professor at the University of Padova in Italy during 2019 and 2020, as well as a Consultant at the College of Public Health in Qatar in 2018, he contributed significantly to the field of parasitology. Dr. Karanis has been a Consultant at Walailak University in Thailand since 2017, where he has provided guidance and international supervision for PhD students.

His academic endeavors include roles as an Invited Professor at the University of Alexandroupolis and the University of Ioannina in Greece, where he delivered lectures on infectious diseases to both undergraduate and postgraduate students. Notably, from 2014 to 2018, Dr. Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at Qinghai University in China.

As a Foreign Expert in the 1000 Talent Plan Recruitment Program, he played a pivotal role in elevating the laboratory to the State Key Laboratory for Plateau Ecology and Agriculture of the Qinghai Province. Dr. Karanis’s contributions extended to advising the Chinese government on research ideas, particularly in waterborne and vectorborne diseases, and his efforts in developing Cryptosporidium culture assays for drug testing garnered recognition and funding from prestigious institutions such as the Bill and Melinda Gates Foundation. His comprehensive involvement in academia, research, and international collaborations underscores his commitment to advancing the field of parasitology and infectious diseases.

 

📚Top Noted Publication